TNF Pharmaceuticals Net Cash Flow 2012-2025 | TNFA

TNF Pharmaceuticals net cash flow from 2012 to 2025. Net cash flow can be defined as the total change in cash for the company over the given period.

TNF Pharmaceuticals Net Cash Flow 2012-2025 | TNFA

TNF Pharmaceuticals net cash flow from 2012 to 2025. Net cash flow can be defined as the total change in cash for the company over the given period.
Related Stocks
Company NameMarket
Cap
Chugai Pharmaceutical (CHGCY)$77.5B
Zoetis (ZTS)$65.6B
Daiichi Sankyo, - (DSNKY)$46.1B
Takeda Pharmaceutical (TAK)$45.9B
BeOne Medicines - (ONC)$32B
Sandoz Group AG (SDZNY)$25.2B
Summit Therapeutics (SMMT)$19.6B
Merck (MKKGY)$16.6B
Shionogi (SGIOY)$14.4B
United Therapeutics (UTHR)$13.2B
Neurocrine Biosciences (NBIX)$13B
Orion OYJ (ORINY)$11B
IPSEN (IPSEY)$10.5B
Corcept Therapeutics (CORT)$7.4B
Madrigal Pharmaceuticals (MDGL)$7.3B
Stevanato Group S.p.A (STVN)$7.3B
Grifols, S.A (GRFS)$6.9B
Ionis Pharmaceuticals (IONS)$6.6B
Hikma Pharmaceuticals Plc (HKMPF)$6.2B
Ono Pharmaceutical (OPHLF)$5.2B
Soleno Therapeutics (SLNO)$4.4B
Procaps Group, S.A (PROCF)$3.2B
Hypermarcas (HYPMY)$3B
Crinetics Pharmaceuticals (CRNX)$2.9B
Catalyst Pharmaceuticals (CPRX)$2.6B
NewAmsterdam Pharma (NAMS)$2.5B
AMNEAL PHARMACEUTICALS, INC (AMRX)$2.5B
Centessa Pharmaceuticals (CNTA)$2.1B
Ocular Therapeutix (OCUL)$1.8B
BioCryst Pharmaceuticals (BCRX)$1.8B